Page 1 of Clinical Trials for Advanced Breast Cancer, 986 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer
Last Updated: July 24, 2008
Condition(s): Advanced Breast Cancer
2
Completed
Non-Interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer
Last Updated: November 21, 2007
Condition(s): Advanced Breast Cancer
3
Recruiting
Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers
Last Updated: December 29, 2011
Condition(s): Locally Advanced Breast Cancer; Ductal Histologic Type; Without Her2 Overexpression.
4
Completed
Faslodex Advanced Breast Cancer Local Chinese Study
Last Updated: January 24, 2011
Condition(s): Advanced Breast Cancer
5
Recruiting
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
Last Updated: December 11, 2011
Condition(s): Advanced Breast Cancer
6
Completed
A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)
Last Updated: April 24, 2012
Condition(s): Advanced Breast Cancer; Other Solid Tumors
7
Not yet recruiting
Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer
Last Updated: January 26, 2012
Condition(s): Her2-negative Metastatic Breast Cancer; Her2-negative Locally Advanced Breast Cancer
8
Active, not recruiting
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
Last Updated: April 30, 2012
Condition(s): Advanced Breast Cancer
9
Active, not recruiting
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
Last Updated: March 30, 2012
Condition(s): Locally Advanced Breast Cancer; Metastatic Breast Cancer
10
Recruiting
Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy
Last Updated: March 23, 2012
Condition(s): Locally Advanced Breast Cancer (LABC)
11
Active, not recruiting
Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer
Last Updated: September 7, 2011
Condition(s): Breast Cancer
12
Completed
A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer
Last Updated: May 1, 2012
Condition(s): Solid Tumors; Breast Cancer; Cowden Syndrome
13
Completed
Phase II Dasatinib Study in Advanced Breast Cancer
Last Updated: June 12, 2011
Condition(s): Advanced Breast Cancer
14
Completed
Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer
Last Updated: January 20, 2010
Condition(s): Breast Cancer
15
Active, not recruiting
Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer
Last Updated: April 30, 2012
Condition(s): Advanced Breast Cancer
16
Not yet recruiting
Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
Last Updated: May 25, 2011
Condition(s): Breast Cancer Stage II; Breast Cancer Stage III
17
Recruiting
A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer
Last Updated: February 5, 2010
Condition(s): Advanced Breast Cancer
18
Active, not recruiting
A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer
Last Updated: May 7, 2012
Condition(s): Advanced Breast Cancer
19
Completed
BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
Last Updated: August 4, 2011
Condition(s): Breast Cancer
20
Recruiting
HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer
Last Updated: June 5, 2009
Condition(s): Advanced Breast Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Advanced+Breast+Cancer

Page 1 of Clinical Trials for Advanced Breast Cancer, 986 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About